SeraCare Seraseq Inherited Cardiomyopathy Reference Material

SeraCare Life Sciences has launched the Seraseq Inherited Cardiomyopathy Reference Material, a multiplexed reference material for hypertrophic cardiomyopathy (HCM) testing by next-generation sequencing. It was developed in collaboration with Birgit Funke, director of clinical research and development at the Partners Healthcare Laboratory for Molecular Medicine. The Seraseq reference material combines ten common pathogenic and/or technically challenging variants for HCM in a well characterized genomic background at a 50 percent target allele frequency, the company said. This is the first testing  control product to be launched after the company's research on testing controls was published online in the Journal of Molecular Diagnostics earlier this year.